Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients
Authors:
- Chiu-Ching HuangCHChiu-Ching Huang
- Chun-Chen YuCYChun-Chen Yu
- Huan-Yu YangHYHuan-Yu Yang
- Feng-Rong ChuangFCFeng-Rong Chuang
- Chih-Wei YangCYChih-Wei Yang
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 42 (3) , 524-531
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Incorporating patient preferences into randomized trialsJournal of Clinical Epidemiology, 2000
- Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatmentsKidney International, 1999
- Glycation of Human .beta.2-Microglobulin in Patients with Hemodialysis-Associated Amyloidosis: Identification of the Glycated SitesBiochemistry, 1994
- Use of Hemodiafiltration to Enhance Delivered DialysisASAIO Journal, 1994
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.Journal of Clinical Investigation, 1994
- Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.Journal of Clinical Investigation, 1993
- Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.Journal of Experimental Medicine, 1991
- Effectiveness of Push/Pull Hemodiafiltration Using Large‐Pore Membrane for Shoulder Joint Pain in Long‐Term Dialysis PatientsArtificial Organs, 1990
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988